Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Aubagio® significantly reduced risk of new clinical relapse or MRI lesion in multiple sclerosis study
Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica.
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression.
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
Daytime sleepiness versus fatigue in patients with multiple sclerosis: A systematic review on the Epworth sleepiness scale as an assessment tool.
Microglia in health and disease.
The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.
You-Gui pills promote nerve regeneration by regulating netrin1, DCC and Rho family GTPases RhoA, Racl, Cdc42 in C57BL/6 mice with experimental autoimmune encephalomyelitis.
The use of hematopoietic stem cells in autoimmune diseases.
Biogen Idec receives notification of PDUFA date extension
CCL genes in multiple sclerosis and systemic lupus erythematosus.
Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients with Relapsing-Remitting Multiple Sclerosis.
Tumefactive multiple sclerosis presenting with tonic-clonic seizure.
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).
The employment concerns of Americans with multiple sclerosis: Perspectives from a national sample.
Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis.
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis.
JC polyomavirus mutants escape antibody-mediated neutralization.
[Immunomodulation and neuroprotection in optic neuritis].
Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study.
The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis.

Pages